HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yassine Taoufik Selected Research

Dacarbazine (DIC)

8/2023Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yassine Taoufik Research Topics

Disease

9Progressive Multifocal Leukoencephalopathy
01/2022 - 04/2001
7Rheumatoid Arthritis
01/2017 - 04/2011
5Hodgkin Disease (Hodgkin's Disease)
08/2023 - 01/2014
5Lymphoma (Lymphomas)
12/2021 - 11/2017
4Multiple Sclerosis
01/2022 - 05/2013
3Infections
10/2019 - 10/2008
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2020
2Lymphopenia (Lymphocytopenia)
01/2021 - 09/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2021
2Axial Spondyloarthritis
01/2018 - 10/2016
2Acquired Immunodeficiency Syndrome (AIDS)
09/2008 - 04/2001
1Breast Neoplasms (Breast Cancer)
01/2022
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2022
1COVID-19
01/2021
1Back Pain (Backache)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2017
1Necrosis
10/2016
1HIV Infections (HIV Infection)
11/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2013
1Autoimmune Diseases (Autoimmune Disease)
04/2011
1Food Hypersensitivity (Food Allergy)
07/2010
1Persistent Infection
05/2004

Drug/Important Bio-Agent (IBA)

8Rituximab (Mabthera)FDA Link
11/2017 - 04/2011
3CytokinesIBA
12/2021 - 04/2011
3Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2011
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 01/2020
2Natalizumab (Tysabri)FDA Link
01/2020 - 05/2013
2Interleukin-7 (Interleukin 7)IBA
10/2019 - 09/2014
2Interleukin-33IBA
01/2017 - 12/2016
1Brentuximab VedotinIBA
08/2023
1Dacarbazine (DIC)FDA LinkGeneric
08/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2023
1Vinblastine (Vinblastine Sulfate)FDA Link
08/2023
1HLA-B Antigens (HLA-B)IBA
01/2022
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2022
1Dimethyl FumarateIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Daunorubicin (Cerubidine)FDA LinkGeneric
11/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017
1Prednisolone (Predate)FDA LinkGeneric
11/2017
1EnzymesIBA
12/2016
1ImmunosorbentsIBA
12/2016
1AntibodiesIBA
10/2016
1AntigensIBA
01/2014
1Immunoglobulin G (IgG)IBA
01/2014
1ChemokinesIBA
09/2013
1Monoclonal AntibodiesIBA
04/2011
1BasiliximabFDA Link
07/2010
1Cidofovir (Vistide)FDA Link
09/2008
1Viral RNAIBA
05/2004
1Capsid Proteins (Capsid Protein)IBA
04/2001

Therapy/Procedure

15Therapeutics
01/2022 - 04/2001
5Highly Active Antiretroviral Therapy (HAART)
01/2011 - 04/2001
2Immunotherapy
01/2021 - 10/2019
1Art Therapy
08/2023
1Length of Stay
01/2021
1Biological Therapy
01/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2014
1Liver Transplantation
07/2010